Search
for
Sort by
Research 481–510 of 775
- The Sebaceous Gland - Friend or Foe?
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: A case report
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Ruxolitinib for the treatment of severe alopecia areata
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib
- A Review on the Use and Effectiveness of JAK Inhibitor in the Management of Lichen Planopilaris
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Alopecia areata – Aktuelles Verständnis und Management
- Abrocitinib in the Treatment of Severe Alopecia Areata in a Pediatric Patient: A Case Report
- Real-world Burden of Disease and Clinical Characteristics of Alopecia Areata Among Adults in Brazil: Results from a Cross-sectional Survey
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Recent Insight on the Management of Lupus Erythematosus Alopecia
- Upadacitinib for the Management of Alopecia Totalis and Subtotalis in Pediatric Patients: A Case Series
- Could baricitinib treat frontal fibrosing alopecia and facial papules?